−15.87 MUSD
658.50 KUSD
30.04 M
About Acro Biomedical Co., Ltd.
Acro Biomedical Co. Ltd. engages in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. Its products include cordycepin, metallothionein, marine elements, embryonic nutrients, and active compound of antodia cinnamomea. The company was founded on September 24, 2014 and is headquartered in Fishers, IN.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ACBM is 0.1050 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Acro Biomedical Co., Ltd. stocks are traded under the ticker ACBM.
ACBM stock is 0% volatile and has beta coefficient of −6.25. Check out the list of the most volatile stocks — is Acro Biomedical Co., Ltd. there?
Yes, you can track Acro Biomedical Co., Ltd. financials in yearly and quarterly reports right on TradingView.
No, ACBM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ACBM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Acro Biomedical Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 1.00 employees. See our rating of the largest employees — is Acro Biomedical Co., Ltd. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Acro Biomedical Co., Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Acro Biomedical Co., Ltd. stock shows the sell signal. See more of Acro Biomedical Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.